Jenny Lin: A Leader Building Quality Organizational Systems
Jenny Lin, the Chief Operating Officer and Board Member of CMIC Inc., holds 27 years of executive/lab management experience in bio-analytical and analytical laboratory operations in support of drug discovery, pre-clinical and clinical drug development. Moreover, she is proficient in GLP, GMP, GCP, OECD, ICH and 21 CFR part 11 regulations and in business strategic planning and execution. Her expertise includes building organizational quality system, staff training, bioanalytical/analytical method development/validation, bioanalytical sample analysis, analytical development for CMC submission, chromatography purification, stability studies, reference standard certification, QC support for GMP manufacture. She has been also a selected member for Global Bioanalysis Consortium (GBC) making recommendations for global Bioanalysis harmonization. She serves as editorial board member for peer reviewed journal and chair for international conferences.
The bellow are the highlights of the Interview with Insights Success a top business magazines.
Future of CMIC Group
CMIC Group’s CREED as a corporate philosophy, consists of Wellbeing, Challenge, Change and Communication (W&3Cs). The company has been applying this philosophy to continuously evolve itself in line with market changes, and will do so in the future. Moreover, by further expanding from the current “Pharmaceutical Value Creator” (PVC) business model, the company has an aspiration to become a “Personal Healthcare Value Creator” (PHVC) to address the up-coming personalized medicine movement and individual patient quality of life.
Source URL
Comments
Post a Comment